Publications
Showing 511 to 520 of 561 Publications
Title | Authors | Year | Journal |
---|---|---|---|
Alzheimer’s environmental and genetic risk scores are differentially associated with general cognitive ability and dementia severity. | Andrews, S.J., McFall, G.P.**, Dixon, R.A.**, Cherbuin, N., Eramudugolla, R., Anstey, K.J. | 2019 | Alzheimer Disease & Associated Disorders |
Alzheimer’s Disease Neuroimaging Initiative. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease. | Pascoal T.A.**, Mathotaarachchi S.**, Shin M.**, Park A.Y., Mohades S., Benedet A.L.**, Kang M.S., Massarweh G., Soucy J.P.**, Gauthier S.**, Rosa-Neto P.** | 2018 | European Journal of Nuclear Medicine and Molecular Imaging |
Alzheimer Disease, biomarkers, and clinical symptoms – Quo Vadis? | Montero-Odasso M*, Ismail Z*, Camicioli R* | 2020 | JAMA Neurology |
Allocating Scarce Resources to Persons with Dementia During a Pandemic | Smith EE, Couillard P, Fisk JD, Ismail Z, Montero-Odasso M, Robillard J, Vedel I, Sivananthan S, Gauthier S. | 2020 | Canadian Geriatrics Journal |
Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation | Ruthirakuhan M, Herrmann N*, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE*, Kiss A, Lanctôt KL* | 2019 | Geriatr Psychiatry Neurol |
Ageism and COVID-19: What does our society’s response say about us? | Fraser S*, Lagacé M, Bongué B, Ndeye N, Guyot J, Bechard L**, Garcia L, Taler V, CCNA Social Inclusion and Stigma Working Group, Adam S, Beaulieu M, Bergeron CD, Boudjemadi V, Desmette D, Donizzetti AR, Éthier S, Garon S, Gillis M, Levasseur M, Lortie-Lussier M, Marier P, Robitaille A, Sawchuk K, Lafontaine C, Tougas F. | 2020 | Age and Ageing |
Ageism and COVID-19: what does our society’s response say about us? | Fraser, S.*, Lagacé, M*, Bongué, B., Ndeye, N., Guyot, J., Bechard, L.**, Garcia, L., Taler, V., Members of the CCNA Social Inclusion and Stigma Working Group*, Adam, S., Beaulieu, M., Bergeron, C.D., Boudjemadi, V., Desmette, D., Donizzetti, A. R., Éthier, S., Garon, S., Gillis, M., Levasseur, M., Lortie-Lussier, M., Marier, P., Robitaille, A., Sawchuk, K., Lafontaine, C., & Tougas, F. | 2020 | Age and Ageing |
Ageism and COVID-19: what does our society’s response say about us? | Fraser, S.*, Lagacé, M*, Bongué, B., Ndeye, N., Guyot, J., Bechard, L.**, Garcia, L., Taler, V.*, Members of the CCNA Social Inclusion and Stigma Working Group*, Adam, S., Beaulieu, M., Bergeron, C.D., Boudjemadi, V., Desmette, D., Donizzetti, A. R., Éthier, S., Garon, S., Gillis, M., Levasseur, M., Lortie-Lussier, M., Marier, P., Robitaille, A., Sawchuk, K., Lafontaine, C., & Tougas, F. | 2020 | Age and Ageing |
Age-related deregulation of TDP-43 after stroke enhances NF-kappaB-mediated inflammation and neuronal damage | Thammisetty, S.S., Pedragosa, J., Weng, Y.C., Calon, F.**, Planas, A., Kriz, J.** | 2018 | Journal of Neuroinflammation |
Age at Onset of Parkinson’s Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations | Yahalom G, Rigbi A, Israeli-Korn S, Krohn L, Rudakou U, Ruskey JA, Benshimol L, Tsafnat T, Gan-Or Z*, Hassin-Baer S, Greenbaum L | 2020 | Journal of Parkinson's Disease |
Showing 511 to 520 of 561 Publications